Therapeutics for the treatment of spondyloarthritis: what, when and whom

ISSN： 1758-4272

Source： International Journal of Clinical Rheumatology, Vol.8, Iss.1, 2013-02, pp. : 73-88

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aldosterone to Renin Ratio (ARR) in Clinical use, with Reference to the Primary Care Setting: ARR to Whom, When, How, What for?

Current Hypertension Reviews, Vol. 4, Iss. 4, 2008-11 ,pp. : 227-233

Bentham Science Publishers

Access to resources Recommend Favorite

Which Biomarker is Useful to Evaluate as a Treatment Outcome in Spondyloarthritis?

Current Rheumatology Reviews, Vol. 5, Iss. 3, 2009-08 ,pp. : 165-168

Bentham Science Publishers

Access to resources Recommend Favorite

Laparoscopic myomectomy today: Why, when and for whom?

By Nezhat Farr

Human Reproduction, Vol. 11, Iss. 5, 1996-05 ,pp. : 933-934

Oxford University Press

Access to resources Recommend Favorite

When (and what) is an egg?

By Boden Jane Hunt Jennifer Williams David

Human Fertility, Vol. 5, Iss. 2, 2002-01 ,pp. : 47-50

Informa Healthcare

Access to resources Recommend Favorite

When IVF treatment fails

By Boden Jane

Human Fertility, Vol. 10, Iss. 2, 2007-06 ,pp. : 93-98

Informa Healthcare

Access to resources Recommend Favorite